公开(公告)号：US20240335439A1

公开(公告)日：2024-10-10

申请号：US18681340

申请日：2022-08-16

Applicant: THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY

Inventor： Xiuju LUO ,  Jun PENG ,  Yiyue ZHANG ,  Mingrui LI

IPC: A61K31/497 ,  A61P9/10 ,  A61P25/00 ,  A61P25/28

CPC classification number: A61K31/497 ,  A61P9/10 ,  A61P25/00 ,  A61P25/28

Abstract: A use of and method for telaprevir in the preparation of a drug and a cytoprotective drug for treating ischemia/reperfusion injury. Telaprevir is used for the preparation of a drug for treating ischemia/reperfusion injury, in particular for treating myocardial cells and nerve cell damage, said drug having in particular a good protective effect on heart and cerebral ischemia/reperfusion (myocardial infarction and ischemic stroke), and can significantly alleviate heart and cerebral ischemia/reperfusion injury.